ApoIII and the treatment and diagnosis of diabetes
US8716241B2 · kind B2 · utility
9Cited by
2References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 5, 2013 |
| Grant date | May 6, 2014 |
| Priority date | — |
| Expiry date | Jul 5, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides methods of identifying candidate compounds for the treatment of type I diabetes and also provides methods for treating patients with type I diabetes and for limiting pancreatic beta cell apoptosis. The present invention also provides methods for diagnosing type I diabetes or a propensity to develop type I diabetes and methods for identifying diabetic patients to be treated with anti-apoCIII therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.